Overview

BAY2586116 Nasal Spray and OSA Severity

Status:
Recruiting

Trial end date:
2023-07-01

Target enrollment:

Participant gender:

Summary

This investigator-initiated study aims to determine the effects of BAY2586116 (a novel TASK channel blocker nasal spray) on sleep apnoea severity and the potential influence of route of breathing.

Phase:

Phase 1

Details

Lead Sponsor:

Flinders University

Collaborator:

Bayer